ICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.

Lehdistö/media: Press/Media

Aikajakso25 maaliskuuta 2020

Käsittely mediassa

1

Käsittely mediassa

  • NimiICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.
    Medianimi / kanavaThe Financial Express
    MaaIndia
    Julkaisupäivämäärä25/03/20
    HenkilötNivedita Gupta